Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dual renin-angiotensin system blockade and phosphate binding in chronic kidney disease
2008-004099-26Phase 4Completed
- Sponsor
- Department of Nephrology
- Start
- Jul 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of enalapril, irbesartan and lanthanum carbonate in chronic kidney disease (CKD) (2 arms), sponsored by Department of Nephrology. Primary endpoint: Preservation of kidney function. Started Jul 2009; status: completed.
02
Drugs
enalaprilirbesartanlanthanum carbonate
03
Conditions
chronic kidney disease (CKD)
Beyond the preview
Go deeper on 2008-004099-26.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2008-004099-26.